tis, and opportunities for effective patient self- 
management; and 
‘‘(B) may give priority to reaching high- 
risk or underserved populations. 
‘‘(4) COLLABORATION.—In carrying out this 
subsection, the Secretary shall consult and collabo-
rate with stakeholders from the public, private, and 
nonprofit sectors with expertise relating to arthritis 
control, prevention, and treatment. 
‘‘(5) ELIGIBLE ENTITY.—For purposes of this 
subsection, the term ‘eligible entity’ means a public 
or private nonprofit entity that demonstrates to the 
satisfaction of the Secretary, in the application de-
scribed in subsection (e), the ability of the entity to 
carry out the activities described in paragraph (1). 
‘‘(d) COMPREHENSIVE STATE GRANTS.— 
‘‘(1) IN GENERAL.—Under the Plan, the Sec-
retary may award grants to eligible entities to pro-
vide support for comprehensive arthritis control and 
prevention programs and to enable such entities to 
provide public health surveillance, prevention, and 
control activities related to arthritis and other rheu-
matic diseases. 
‘‘(2) APPLICATION.—The Secretary may only 
award a grant under this subsection to an eligible
entity that submits to the Secretary an application 
at such time, in such manner, and containing such 
agreements, assurances, and information as the Sec-
retary may require, including a comprehensive ar-
thritis control and prevention plan that— 
‘‘(A) is developed with the advice of stake-
holders from the public, private, and nonprofit 
sectors that have expertise relating to arthritis 
control, prevention, and treatment that increase 
the quality of life and decrease the level of dis-
ability; 
‘‘(B) is intended to reduce the morbidity of 
arthritis, with priority on preventing and con-
trolling arthritis in at-risk populations and re-
ducing disparities in arthritis prevention, diag-
nosis, management, and quality of care in un-
derserved populations; 
‘‘(C) describes the arthritis-related services 
and activities to be undertaken or supported by 
the entity; and 
‘‘(D) demonstrates the relationship the en-
tity has with the community and local entities 
and how the entity plans to involve such com-
munity and local entities in carrying out the ac-
tivities described in paragraph (1).
‘‘(3) USE OF FUNDS.—An eligible entity may 
use amounts received under a grant awarded under 
this subsection to conduct, in a manner consistent 
with the comprehensive arthritis control and preven-
tion plan submitted by the entity in the application 
under paragraph (2)— 
‘‘(A) public health surveillance and epide-
miological activities relating to the prevalence of 
arthritis and assessment of disparities in arthri-
tis prevention, diagnosis, management, and 
care; 
‘‘(B) public information and education pro-
grams; and 
‘‘(C) education, training, and clinical skills 
improvement activities for health professionals, 
including allied health personnel. 
‘‘(4) ELIGIBLE ENTITY.—For purposes of this 
subsection, the term ‘eligible entity’ means a State 
or an Indian tribe. 
‘‘(e) GENERAL APPLICATION.—The Secretary may 
only award a grant under subsection (b) or (c) to an entity 
that submits to the Secretary an application at such time, 
in such manner, and containing such agreements, assur-
ances, and information as the Secretary may require, in-
cluding a description of how funds received under a grant
awarded under such subsection will supplement or fulfill 
unmet needs identified in a comprehensive arthritis con-
trol and prevention plan of the entity. 
‘‘(f) DEFINITIONS.—For purposes of this section: 
‘‘(1) INDIAN TRIBE.—The term ‘Indian tribe’ 
has the meaning given such term in section 4(e) of 
the Indian Self-Determination and Education Assist-
ance Act. 
‘‘(2) STATE.—The term ‘State’ means any of 
the 50 States, the District of Columbia, the Com-
monwealth of Puerto Rico, the Virgin Islands, Amer-
ican Samoa, Guam, and the Northern Mariana Is-
lands. 
‘‘(g) AUTHORIZATION OF APPROPRIATIONS.—There 
are authorized to be appropriated to carry out this sec-
tion— 
‘‘(1) for fiscal year 2012, $14,600,000; 
‘‘(2) for fiscal year 2013, $16,000,000; 
‘‘(3) for fiscal year 2014, $17,700,000; 
‘‘(4) for fiscal year 2015, $19,400,000; and 
‘‘(5) for fiscal year 2016, $21,400,000.’’.